Loading stock data…
Loading stock data…
US$3.10
Get one email when TVRD crosses your level. Checked every 15 minutes during market hours.
▲ +0.02 (0.65%)up today
USD · data via Finnhub · delayed/cached up to 1–5 min
Get an AI-written, balanced deep-dive — performance, valuation, technicals, and the bull vs. bear case. Sign in to get started.
RSI (14-day)
51.9
NeutralAbove 70 can signal overbought; below 30, oversold.
MACD
0.10
Bullish momentumMACD above its signal line (0.01).
50-day average
3.12
Price belowShort-term trend reference.
200-day average
5.58
Price belowLong-term trend reference.
Daily values · indicators are descriptive, not trading advice
Healthcare · Biotechnology
Cara Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for fibrosis-driven diseases. The company’s current portfolio centers on novel, oral small-molecule treatments that target STAT3, a signaling pathway involved in inflammatory and fibrotic processes. Through this work, Cara Therapeutics addresses conditions where abnormal tissue scarring can drive serious organ damage and limited treatment options. The company operates in the biotechnology and dru…
www.caratherapeutics.com4 strong buy · 6 buy · 4 hold · 1 sell · 0 strong sell (15 analysts, 2026-07-01)
4 strong buy · 5 buy · 4 hold · 1 sell · 0 strong sell (14 analysts, 2026-06-01)
4 strong buy · 5 buy · 4 hold · 1 sell · 0 strong sell (14 analysts, 2026-05-01)
4 strong buy · 5 buy · 5 hold · 0 sell · 0 strong sell (14 analysts, 2026-04-01)
| Quarter | Estimate | Actual | Result |
|---|---|---|---|
| 2026-05-26 | 2.34 | 3.14 | ✓ Beat |
| 2026-04-21 | 1.52 | 2.16 | ✓ Beat |
| 2026-03-31 | -0.57 | -0.78 | ✗ Miss |
| 2025-11-13 | -0.81 | -0.59 | ✓ Beat |
| 2025-11-04 | 3.16 | 3.01 | ✗ Miss |
| 2025-10-06 | 0.82 | 0.85 | ✓ Beat |
| 2025-08-14 | -0.39 | 0.51 | ✓ Beat |
Companies in the same industry, via Finnhub